123 related articles for article (PubMed ID: 12779240)
1. Cis-[Pt(Cl)2(pyridine)(5-SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzyme.
Colangelo D; Ghiglia AL; Viano I; Cavigiolio G; Osella D
Biometals; 2003 Dec; 16(4):553-60. PubMed ID: 12779240
[TBL] [Abstract][Full Text] [Related]
2. Might telomerase enzyme be a possible target for trans-Pt(II) complexes?
Colangelo D; Ghiglia A; Viano I; Mahboobi H; Ghezzi A; Cassino C; Osella D
J Inorg Biochem; 2004 Jan; 98(1):61-7. PubMed ID: 14659633
[TBL] [Abstract][Full Text] [Related]
3. A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.
Furuta M; Nozawa K; Takemura M; Izuta S; Murate T; Tsuchiya M; Yoshida K; Taka N; Nimura Y; Yoshida S
Int J Cancer; 2003 May; 104(6):709-15. PubMed ID: 12640677
[TBL] [Abstract][Full Text] [Related]
4. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
Zhang RG; Zhang RP; Wang XW; Xie H
Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
[TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
[TBL] [Abstract][Full Text] [Related]
6. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
7. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
Herbert BS; Pongracz K; Shay JW; Gryaznov SM
Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
[TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibitor imetelstat has preclinical activity across the spectrum of non-small cell lung cancer oncogenotypes in a telomere length dependent manner.
Frink RE; Peyton M; Schiller JH; Gazdar AF; Shay JW; Minna JD
Oncotarget; 2016 May; 7(22):31639-51. PubMed ID: 27192120
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of human telomeric G-quadruplex and inhibition of telomerase activity by propeller-shaped trinuclear Pt(II) complexes.
Xu CX; Shen Y; Hu Q; Zheng YX; Cao Q; Qin PZ; Zhao Y; Ji LN; Mao ZW
Chem Asian J; 2014 Sep; 9(9):2519-26. PubMed ID: 24996049
[TBL] [Abstract][Full Text] [Related]
10. A highly selective telomerase inhibitor limiting human cancer cell proliferation.
Damm K; Hemmann U; Garin-Chesa P; Hauel N; Kauffmann I; Priepke H; Niestroj C; Daiber C; Enenkel B; Guilliard B; Lauritsch I; Müller E; Pascolo E; Sauter G; Pantic M; Martens UM; Wenz C; Lingner J; Kraut N; Rettig WJ; Schnapp A
EMBO J; 2001 Dec; 20(24):6958-68. PubMed ID: 11742973
[TBL] [Abstract][Full Text] [Related]
11. Screening of telomerase inhibitors.
Kleideiter E; Piotrowska K; Klotz U
Methods Mol Biol; 2007; 405():167-80. PubMed ID: 18369824
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
13. Growth arrest, apoptosis, and telomere shortening of Barrett's-associated adenocarcinoma cells by a telomerase inhibitor.
Shammas MA; Koley H; Beer DG; Li C; Goyal RK; Munshi NC
Gastroenterology; 2004 May; 126(5):1337-46. PubMed ID: 15131795
[TBL] [Abstract][Full Text] [Related]
14. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
[TBL] [Abstract][Full Text] [Related]
15. Agents that target telomerase and telomeres.
Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
[TBL] [Abstract][Full Text] [Related]
16. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
Chen Z; Koeneman KS; Corey DR
Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
[TBL] [Abstract][Full Text] [Related]
17. Distinct modulation of telomere length in two T-lymphoblastic leukemia cell lines by cytotoxic nucleoside phosphonates PMEG and PMEDAP.
Hájek M; Cvilink V; Votruba I; Holý A; Mertlíková-Kaiserová H
Eur J Pharmacol; 2010 Sep; 643(1):6-12. PubMed ID: 20599933
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
19. Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.
Kim JH; Kim JH; Lee GE; Kim SW; Chung IK
Biochem J; 2003 Jul; 373(Pt 2):523-9. PubMed ID: 12689331
[TBL] [Abstract][Full Text] [Related]
20. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
